Related Image: Y chromosome study sheds light on Athapaskan migration to southwest US |
(Date:1/8/2009)...ls are born every day in the brain,s hippocampus, ...y. Reporting in the January 1 issue of Science , ...hool of Medicine have discovered that the birth of...depends on a protein that is involved in changing ..., "How is it that when you see someone you met t...
(Date:1/8/2009)...A, N.Y. The evolutionary history of diatoms -- ab...ns of carbon dioxide from the air each year -- nee...dy. The findings suggest that after a sudden rise ...t 33 million years ago -- trends that coincided wi...d in the Jan. 8 issue of the journal Nature . , ...
(Date:1/8/2009)...ochelle, NY, January 8, 2009Natural gas, believed ...ultrafine airborne particulate matter when burned ...aters, according to a report in the December 2008 ...ineering Science journal, a peer-reviewed journal...available free online at www.liebertpub.com/ees ...
(Date:1/8/2009)...ice University study published in the Journal of ...including sexual ones, are conveyed in human sweat...gy at Rice, looked at how the brains of female vol...sweat from men. The results of the experiment indi...ion, including human sexual sweat. , Scientists ...
Breaking Biology News(10 mins):Growth of new brain cells requires 'epigenetic' switch 2Decline of carbon-dioxide-gobbling plankton coincided with ancient global cooling 2Align Technology Announces 2450 Million Stock Repurchase Program 4954 1Align Technology Announces 2450 Million Stock Repurchase Program 4954 2Align Technology Announces 2450 Million Stock Repurchase Program 4954 3Quantum Immunologics Inc and the South Alabama Medical Science Foundation Announce an Early Clinical Evaluation of a Novel Immuno therapeutic Vaccin 1935 1Quantum Immunologics Inc and the South Alabama Medical Science Foundation Announce an Early Clinical Evaluation of a Novel Immuno therapeutic Vaccin 1935 2Quantum Immunologics Inc and the South Alabama Medical Science Foundation Announce an Early Clinical Evaluation of a Novel Immuno therapeutic Vaccin 1935 3Webcast of QIAGEN N V s 28Nasdaq 3A QGEN 29 First Quarter 2008 Financial Results Call Set for May 6 1931 1Webcast of QIAGEN N V s 28Nasdaq 3A QGEN 29 First Quarter 2008 Financial Results Call Set for May 6 1931 2Researchers develop method for transmitting medical images via cell phones 4949 1Researchers develop method for transmitting medical images via cell phones 4949 2Researchers develop method for transmitting medical images via cell phones 4949 3Researchers develop method for transmitting medical images via cell phones 4949 4...the Bronx Zoo-based Wildlife Conservation Society,...ean Union project CURESS near Chad,s Zakouma Natio..., most of them missing only their tusks -- a sure ...of this renowned protected area. , Mike Fay, a WCS...in-Residence, and his team discovered five separat...
...nes with a single injection into a vein holds prom...ases of the heart, University of Florida researche...successfully reverse symptoms in mice with a form ... also tested the virus-based delivery method in mo...rt muscle cells, and the effect persisted for mont...
...using a new technique, scientists can determine wh...ton, and how this affects Earth,s climate. , Phyt...rtant part of the ocean food chain. By knowing wha...nd how ecosystems respond to climate change. , T...Pacific Ocean. It is an area of the ocean that pla...
...t the Salk Institute for Biological Studies and th... the genome-wide DNA methylation pattern of the pl... the plant world - in one big sweep. , "In a sin...anecdotal findings and then some," says senior aut...nstitute,s Plant Biology Laboratory. "Previously, ...
Other Biology News:Widespread elephant slaughter discovered in Chad 2UF scientists test improved gene therapy method for hereditary heart conditions 2UF scientists test improved gene therapy method for hereditary heart conditions 3UF scientists test improved gene therapy method for hereditary heart conditions 4NASA study solves ocean plant mystery 2NASA study solves ocean plant mystery 3In a technical tour de force, Salk scientists take a global view of the epigenome 2In a technical tour de force, Salk scientists take a global view of the epigenome 3(Date:1/8/2009)... Orexigen(R) Therapeutics... first of four Phase 3 trials of its,lead investi... release,(SR)/bupropion SR) met its co-primary an...reduction in body weight, improvements in markers ... food craving measures. , In this trial, wh...
(Date:1/8/2009)...n Spent Last 10 Years Helping Implement World Bank..., Mass., Jan. 8 Abt Associates ann...as a Principal Associate and HIV/AIDS and Infectio...physician in the United Kingdom and European Union...ive experience working on HIV/AIDS and infectious ...
(Date:1/8/2009)...wswire/ - Aegera Therapeutics Inc. announced today...hase 2 study of AEG35156, their targeted antisense... oncology indications. , The study, entitled "A P...of the X-Linked Inhibitor of Apoptosis (XIAP) Anti...in/Paclitaxel or the Combination of Carboplatin/Pa...
(Date:1/8/2009)... 8 Karolinska Development AB (publ...sue, raising SEK 147 million,(USD 19 million). It...ng AB,Tredje AP-fonden; Ostersjostiftelsen; Nasu...nvest - took their share of the new issue, while n...rolinska Development was advised by EFG,Bank AB. ...
Breaking Biology Technology:Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 2Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 3Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 4Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 5Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 6Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 7Dr. John Stephen Osika, HIV/AIDS and Infectious Disease Expert, Joins Abt Associates 2Aegera Therapeutics Initiates A Randomized Phase 2 Combination Study of AEG35156 for 1st Line Treatment of Non-Small Cell Lung Cancer 2Karolinska Development Closes Fully Subscribed New Share Issue 2Karolinska Development Closes Fully Subscribed New Share Issue 3... investor network Silicon Pastures will invest $...is developing a next-generation credit card proces...s not unusual for Wisconsin-based investors to loo...anaging director of Silicon Pastures, said this in... in the right place. , ,"Our investors traditiona...
... joined 33 other states in filing a price-fixing l...tates filed the complaint in San Francisco federal...om access memory microchips (D-RAMs), accusing the...s from 1998 to 2002. , ,The complaint alleges that... the DRAM microchips used in many applications, in...
...hter Molly was 18 months old, Maureen Fitzgerald k...compared to other children the same age. , ,She d...anguage she heard, she pulled her hair and was agg...l sensitivity to sounds such as running water. , ,...retending to bathe and play with the doll. My daug...
...are , a unit of General Electric Co. , has announ...EHR) has received certification for use in physici...mission for Healthcare Information Technology . , ...proval for providers and an assurance to customers...ility, and security criteria set forth by the comm...
Other Biology Technology:Wisconsin joins price-fixing suit vs. D-RAM makers 2RelateNow.com goes live to tackle autism 2RelateNow.com goes live to tackle autism 3RelateNow.com goes live to tackle autism 4... detects an ~185 kDa protein, corresponding to the...at tyrosine 1248 on SDS-PAGE immunoblots. The affi...nst the non-phosphorylated peptide to remove antib...of the protein. In cell lines where EGFR is highl...
Anti-GOSR2 Monoclonal AntibodyOther Sub-Family: not assigned-Other Applications: Immunocytochemistry, Immunoprecipitation, Western Blot
Immunogen: Synthetic peptide corresponding to amino acids 22-37 SGHKSEEKREKMKRTL Antigen Family: Regulator of G-protein signalling; Antigen Subfamily: not assigned-Regulator of G-protein sig
Anti-DNA Polymerase a, Human Description: 50 l Research Focus: cancer & cell proliferation Storage: 4C Shipping Temperature: 4C
Biology Products: